MyFinsight
Home
Blog
About
Marketable securities
$412,471K
(33.30%↑ Y/Y)
Cash and cash
equivalents
$48,599K
(-7.38%↓ Y/Y)
Prepaid expenses and
other current assets
$8,806K
(51.51%↑ Y/Y)
Total current assets
$469,876K
(27.78%↑ Y/Y)
Other assets and
long-term deposits
$16,064K
(27.57%↑ Y/Y)
Operating lease
right-of-use assets
$638K
(-62.14%↓ Y/Y)
Total assets
$486,578K
(27.38%↑ Y/Y)
Total liabilities and
stockholders' equity
$486,578K
(27.38%↑ Y/Y)
Total stockholders'
equity
$430,564K
(24.72%↑ Y/Y)
Total liabilities
$56,014K
(52.35%↑ Y/Y)
Accumulated deficit
-$713,846K
(-40.17%↓ Y/Y)
Accumulated other
comprehensive (loss) income
-$947K
(-401.59%↓ Y/Y)
Additional paid-in capital
$1,145,349K
(34.09%↑ Y/Y)
Total current
liabilities
$53,014K
(59.85%↑ Y/Y)
Long-term borrowing
$3,000K
(0.00%↑ Y/Y)
Common stock, 0.0001
par value...
$8K
(14.29%↑ Y/Y)
Other current
liabilities
$50,687K
(63.10%↑ Y/Y)
Accounts payable
$1,667K
(78.48%↑ Y/Y)
Operating lease
liabilities, current
$660K
(-42.76%↓ Y/Y)
Back
Back
Balance Sheet
Olema Pharmaceuticals, Inc. (OLMA)
Olema Pharmaceuticals, Inc. (OLMA)
source: myfinsight.com